Wyeth Farma

Wyeth Farma is the Spanish subsidiary of Wyeth, a global pharmaceutical leader that was acquired by Pfizer in 2009 for approximately $68 billion. The company maintains a significant presence in Spain, particularly through its advanced biotechnology manufacturing site located in San Sebastián de los Reyes, Madrid. This facility is a critical hub for Pfizer's global operations, specializing in the production, packaging, and international distribution of high-value biologics and vaccines. Historically, Wyeth Farma has been instrumental in the development of landmark therapies such as the pneumococcal vaccine Prevenar and the TNF inhibitor Enbrel. Today, the company operates as a fully integrated part of Pfizer, focusing on delivering innovative treatments in areas such as oncology, inflammation, and rare diseases. Its Spanish operations continue to play a vital role in both clinical research and the supply of essential medicines to over 150 countries.